PROMISE Registry

PSMA-PET imaging findings by PROMISE are linked to prostate cancer outcome.

To improve our understanding for the relationship between PET  findings and patient survival, we have established an international registry study.

This registry invites imaging sites worldwide that utilize PSMA-PET for a range of different prostate cancer stages and hold data on patient overall survival. Centers are encouraged to contribute PSMA-PET findings to our collective knowledge base.

The PROMISE Registry Study is supported by leading imaging departments worldwide. Our goal is to apply PSMA-PET and PROMISE as powerful tools for survival prediction in patients with prostate cancer.

If you are a medical professional and interested in contributing to the PROMISE PET registry, please reach out.